Drug Discovery Chemistry is a dynamic conference for medicinal and biophysical chemists working in pharma, biotech, and academia. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one’s personal interests by going back and forth among concurrent tracks. New for 2023 is coverage of targeting transcription factors, plus greatly expanded coverage of protein degraders, molecular glues, and artificial intelligence for early drug discovery.
Tom Pesnot (Head of Medicinal Chemistry) will be presenting 2 x posters:
- MolPAL/GCI-Driven Hit Identification of Novel BRPF1b Binders And Harnessing the Biophysical Fragment Screening Sweet Spot to Discover
- New Chemotypes for BRPF1b Inhibition
Find us at booth 412 with Malvern Panalytical – see their new Wavedelta and our posters showcasing it’s use!
